CVI Holdings’s Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares FLAC Stock Holding History

CVI Holdings’s Portfolio FLAC Stock Details FLAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-130,404	Closed	-$1.3M	–	870
2022 Q3	$1.3M	Hold	130,404	–	–	0.1%	294
2022 Q2	$1.29M	Hold	130,404	–	–	0.09%	318
2022 Q1	$1.28M	Buy	130,404 +5,404	+4%	+$52.9K	0.08%	347
2021 Q4	$1.22M	Hold	125,000	–	–	0.08%	331
2021 Q3	$1.22M	Hold	125,000	–	–	0.08%	334
2021 Q2	$1.22M	Hold	125,000	–	–	0.08%	303
2021 Q1	$1.24M	Buy	+125,000	New	+$1.28M	0.09%	279

CVI Holdings's FLAC Position: Q4 2022 in Review

CVI Holdings sold out of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) in Q4 2022, closing a stake of 130,404 shares — an estimated $1.3M sold.

CVI Holdings first reported a position in FLAC in Q1 2021 and held it in 7 quarters. The position peaked at $1.3M in Q3 2022. 0 funds tracked by Wall St. Rank hold FLAC as of Q4 2022.

CVI Holdings reported no remaining Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position as of Q4 2022 after selling out during the quarter.
CVI Holdings sold 130,404 Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares shares in Q4 2022, an estimated $1.3M.
CVI Holdings first reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in Q1 2021 and held it in 7 quarters.
CVI Holdings's Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position peaked at $1.3M in Q3 2022.
0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares as of Q4 2022.

Based on CVI Holdings's 13F filing for Q4 2022, filed 14 Feb 2023.